Absence of cross-toxicity between MET inhibitors in a non-small-cell lung cancer with a MET exon 14 skipping mutation

.

Source: Acta Clinica Belgica - March 18, 2024 Category: General Medicine Authors: Ariane VanderickBeno ît Colineta Pneumology, Université catholique de Louvain (UCL), Brussels, Belgiumb Department of Pneumology, Grand hôpital de Charleroi, Charleroi, Belgium Source Type: research